# Effects of Dihydroberberine (DHB) on GLP-1, Glycemic Control, Appetite, and Mood in Adults With Pre-Diabetes

> **NCT07210684** · NA · RECRUITING · sponsor: **Nanjing Nutrabuilding Bio-tech Co., Ltd.** · enrollment: 54 (estimated)

## Conditions studied

- Prediabetes

## Interventions

- **DIETARY_SUPPLEMENT:** Placebo 400 mg
- **DIETARY_SUPPLEMENT:** Dihydroberberine（DHB）400 mg

## Key facts

- **NCT ID:** NCT07210684
- **Lead sponsor:** Nanjing Nutrabuilding Bio-tech Co., Ltd.
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-06
- **Primary completion:** 2026-01-15
- **Final completion:** 2026-03-15
- **Target enrollment:** 54 (ESTIMATED)
- **Last updated:** 2025-10-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07210684

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07210684, "Effects of Dihydroberberine (DHB) on GLP-1, Glycemic Control, Appetite, and Mood in Adults With Pre-Diabetes". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07210684. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*